Clinical-histological associations in gastroparesis: results from the Gastroparesis Clinical Research Consortium
- PMID: 22339929
- PMCID: PMC3353102
- DOI: 10.1111/j.1365-2982.2012.01894.x
Clinical-histological associations in gastroparesis: results from the Gastroparesis Clinical Research Consortium
Abstract
Background: Cellular changes associated with diabetic (DG) and idiopathic gastroparesis (IG) have recently been described from patients enrolled in the Gastroparesis Clinical Research Consortium. The association of these cellular changes with gastroparesis symptoms and gastric emptying is unknown. The aim of this study was to relate cellular changes to symptoms and gastric emptying in patients with gastroparesis.
Methods: Earlier, using full thickness gastric body biopsies from 20 DG, 20 IG, and 20 matched controls, we found decreased interstitial cells of Cajal (ICC) and enteric nerves and an increase in immune cells in both DG and IG. Here, demographic, symptoms [gastroparesis cardinal symptom index score (GCSI)], and gastric emptying were related to cellular alterations using Pearson's correlation coefficients.
Key results: Interstitial cells of Cajal counts inversely correlated with 4 h gastric retention in DG but not in IG (r = -0.6, P = 0.008, DG, r = 0.2, P = 0.4, IG). There was also a significant correlation between loss of ICC and enteric nerves in DG but not in IG (r = 0.5, P = 0.03 for DG, r = 0.3, P = 0.16, IG). Idiopathic gastroparesis with a myenteric immune infiltrate scored higher on the average GCSI (3.6 ± 0.7 vs 2.7 ± 0.9, P = 0.05) and nausea score (3.8 ± 0.9 vs 2.6 ± 1.0, P = 0.02) as compared to those without an infiltrate.
Conclusions & inferences: In DG, loss of ICC is associated with delayed gastric emptying. Interstitial cells of Cajal or enteric nerve loss did not correlate with symptom severity. Overall clinical severity and nausea in IG is associated with a myenteric immune infiltrate. Thus, full thickness gastric biopsies can help define specific cellular abnormalities in gastroparesis, some of which are associated with physiological and clinical characteristics of gastroparesis.
© 2012 Blackwell Publishing Ltd.
Conflict of interest statement
Figures



References
-
- Parkman HP, Hasler WL, Fisher RS American Gastroenterological A. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology. 2004;127:1592–1622. - PubMed
-
- Camilleri M. Clinical practice. Diabetic gastroparesis. N Engl J Med. 2007;356:820–829. - PubMed
-
- Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med. 2001;161:1989–1996. - PubMed
-
- Wang YR, Fisher RS, Parkman HP. Gastroparesis-related hospitalizations in the United States: trends, characteristics, and outcomes, 1995–2004. Am J Gastroenterol. 2008;103:313–322. - PubMed
Publication types
MeSH terms
Grants and funding
- U01DK073975/DK/NIDDK NIH HHS/United States
- U01 DK074008/DK/NIDDK NIH HHS/United States
- R01 DK057061/DK/NIDDK NIH HHS/United States
- DK84567/DK/NIDDK NIH HHS/United States
- U01 DK073975/DK/NIDDK NIH HHS/United States
- U01 DK074035/DK/NIDDK NIH HHS/United States
- U01 DK073983/DK/NIDDK NIH HHS/United States
- U01DK074008/DK/NIDDK NIH HHS/United States
- U01DK073983,/DK/NIDDK NIH HHS/United States
- U01DK073985/DK/NIDDK NIH HHS/United States
- U01DK073974/DK/NIDDK NIH HHS/United States
- P01 DK068055/DK/NIDDK NIH HHS/United States
- U01 DK074007/DK/NIDDK NIH HHS/United States
- P01 DK68055/DK/NIDDK NIH HHS/United States
- U01 DK073985/DK/NIDDK NIH HHS/United States
- U01DK074007/DK/NIDDK NIH HHS/United States
- DK57061/DK/NIDDK NIH HHS/United States
- U01 DK073974/DK/NIDDK NIH HHS/United States
- P30 DK084567/DK/NIDDK NIH HHS/United States